Counterfeit Drugs Myth and Reality
2.2 Governance, The Hindu, 2026-11-18
The last National Drug Survey (2017) detected counterfeit drugs at just 0.0245% of the Indian market, far below the mythical 25% figure attributed to WHO. Karnataka has not confirmed seizure of fake cancer drugs from a Bengaluru distributor. Pharmacies and distributors invoke immunity under Section 19(3) of the Drugs & Cosmetics Act, 1940. Anti-counterfeiting tech lobbying may raise drug prices. Gaps remain: no licensing framework for drug transporters, raised by the Supreme Court in the 1970s, and WHO's Good Distribution Practices pending for over a decade.